TY - JOUR
T1 - Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning
T2 - The Brain-Predicted Disease Duration Gap
AU - MAGNIMS study group.
AU - Pontillo, Giuseppe
AU - Prados, Ferran
AU - Colman, Jordan
AU - Kanber, Baris
AU - Abdel-Mannan, Omar
AU - Al-Araji, Sarmad
AU - Bellenberg, Barbara
AU - Bianchi, Alessia
AU - Bisecco, Alvino
AU - Brownlee, Wallace J.
AU - Brunetti, Arturo
AU - Cagol, Alessandro
AU - Calabrese, Massimiliano
AU - Castellaro, Marco
AU - Christensen, Ronja
AU - Cocozza, Sirio
AU - Colato, Elisa
AU - Collorone, Sara
AU - Cortese, Rosa
AU - de Stefano, Nicola
AU - Enzinger, Christian
AU - Filippi, Massimo
AU - Foster, Michael A.
AU - Gallo, Antonio
AU - Gasperini, Claudio
AU - Gonzalez-Escamilla, Gabriel
AU - Granziera, Cristina
AU - Groppa, Sergiu
AU - Hacohen, Yael
AU - Harbo, Hanne F. F.
AU - He, Anna
AU - Hogestol, Einar A.
AU - Kuhle, Jens
AU - Llufriu, Sara
AU - Lukas, Carsten
AU - Martinez-Heras, Eloy
AU - Messina, Silvia
AU - Moccia, Marcello
AU - Mohamud, Suraya
AU - Nistri, Riccardo
AU - Nygaard, Gro O.
AU - Palace, Jacqueline
AU - Petracca, Maria
AU - Pinter, Daniela
AU - Rocca, Maria A.
AU - Rovira, Alex
AU - Ruggieri, Serena
AU - Sastre-Garriga, Jaume
AU - Strijbis, Eva M.
AU - Toosy, Ahmed T.
AU - Uher, Tomas
AU - Valsasina, Paola
AU - Vaneckova, Manuela
AU - Vrenken, Hugo
AU - Wingrove, Jed
AU - Yam, Charmaine
AU - Schoonheim, Menno M.
AU - Ciccarelli, Olga
AU - Cole, James H.
AU - Barkhof, Frederik
N1 - Publisher Copyright:
© 2024 American Academy of Neurology.
PY - 2024/11/4
Y1 - 2024/11/4
N2 - Background and Objectives Disentangling brain aging from disease-related neurodegeneration in patients with multiple sclerosis (PwMS) is increasingly topical. The brain-age paradigm offers a window into this problem but may miss disease-specific effects. In this study, we investigated whether a disease-specific model might complement the brain-age gap (BAG) by capturing aspects unique to MS. Methods In this retrospective study, we collected 3D T1-weighted brain MRI scans of PwMS to build (1) a cross-sectional multicentric cohort for age and disease duration (DD) modeling and (2) a longitudinal single-center cohort of patients with early MS as a clinical use case. We trained and evaluated a 3D DenseNet architecture to predict DD from minimally preprocessed images while age predictions were obtained with the DeepBrainNet model. The brain-predicted DD gap (the difference between predicted and actual duration) was proposed as a DD-adjusted global measure of MS-specific brain damage. Model predictions were scrutinized to assess the influence of lesions and brain volumes while the DD gap was biologically and clinically validated within a linear model framework assessing its relationship with BAG and physical disability measured with the Expanded Disability Status Scale (EDSS). Results We gathered MRI scans of 4,392 PwMS (69.7% female, age: 42.8 ± 10.6 years, DD: 11.4 ± 9.3 years) from 15 centers while the early MS cohort included 749 sessions from 252 patients (64.7% female, age: 34.5 ± 8.3 years, DD: 0.7 ± 1.2 years). Our model predicted DD better than chance (mean absolute error = 5.63 years, R2 = 0.34) and was nearly orthogonal to the brain-age model (correlation between DD and BAGs: r = 0.06 [0.00-0.13], p = 0.07). Predictions were influenced by distributed variations in brain volume and, unlike brain-predicted age, were sensitive to MS lesions (difference between unfilled and filled scans: 0.55 years [0.51-0.59], p < 0.001). DD gap significantly explained EDSS changes (B = 0.060 [0.038-0.082], p < 0.001), adding to BAG (ΔR2 = 0.012, p < 0.001). Longitudinally, increasing DD gap was associated with greater annualized EDSS change (r = 0.50 [0.39-0.60], p < 0.001), with an incremental contribution in explaining disability worsening compared with changes in BAG alone (ΔR2 = 0.064, p < 0.001). Discussion The brain-predicted DD gap is sensitive to MS-related lesions and brain atrophy, adds to the brain-age paradigm in explaining physical disability both cross-sectionally and longitudinally, and may be used as an MS-specific biomarker of disease severity and progression.
AB - Background and Objectives Disentangling brain aging from disease-related neurodegeneration in patients with multiple sclerosis (PwMS) is increasingly topical. The brain-age paradigm offers a window into this problem but may miss disease-specific effects. In this study, we investigated whether a disease-specific model might complement the brain-age gap (BAG) by capturing aspects unique to MS. Methods In this retrospective study, we collected 3D T1-weighted brain MRI scans of PwMS to build (1) a cross-sectional multicentric cohort for age and disease duration (DD) modeling and (2) a longitudinal single-center cohort of patients with early MS as a clinical use case. We trained and evaluated a 3D DenseNet architecture to predict DD from minimally preprocessed images while age predictions were obtained with the DeepBrainNet model. The brain-predicted DD gap (the difference between predicted and actual duration) was proposed as a DD-adjusted global measure of MS-specific brain damage. Model predictions were scrutinized to assess the influence of lesions and brain volumes while the DD gap was biologically and clinically validated within a linear model framework assessing its relationship with BAG and physical disability measured with the Expanded Disability Status Scale (EDSS). Results We gathered MRI scans of 4,392 PwMS (69.7% female, age: 42.8 ± 10.6 years, DD: 11.4 ± 9.3 years) from 15 centers while the early MS cohort included 749 sessions from 252 patients (64.7% female, age: 34.5 ± 8.3 years, DD: 0.7 ± 1.2 years). Our model predicted DD better than chance (mean absolute error = 5.63 years, R2 = 0.34) and was nearly orthogonal to the brain-age model (correlation between DD and BAGs: r = 0.06 [0.00-0.13], p = 0.07). Predictions were influenced by distributed variations in brain volume and, unlike brain-predicted age, were sensitive to MS lesions (difference between unfilled and filled scans: 0.55 years [0.51-0.59], p < 0.001). DD gap significantly explained EDSS changes (B = 0.060 [0.038-0.082], p < 0.001), adding to BAG (ΔR2 = 0.012, p < 0.001). Longitudinally, increasing DD gap was associated with greater annualized EDSS change (r = 0.50 [0.39-0.60], p < 0.001), with an incremental contribution in explaining disability worsening compared with changes in BAG alone (ΔR2 = 0.064, p < 0.001). Discussion The brain-predicted DD gap is sensitive to MS-related lesions and brain atrophy, adds to the brain-age paradigm in explaining physical disability both cross-sectionally and longitudinally, and may be used as an MS-specific biomarker of disease severity and progression.
UR - https://www.scopus.com/pages/publications/85208517085
U2 - 10.1212/WNL.0000000000209976
DO - 10.1212/WNL.0000000000209976
M3 - Article
C2 - 39496109
SN - 0028-3878
VL - 103
SP - e209976
JO - Neurology
JF - Neurology
IS - 10
M1 - e209976
ER -